These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 8809569

  • 1. [Basic and clinical aspects of hepatitis virus carriers].
    Shimoyama R, Sekiguchi S.
    Hokkaido Igaku Zasshi; 1996 Jul; 71(4):427-48. PubMed ID: 8809569
    [Abstract] [Full Text] [Related]

  • 2. Markers of hepatitis B infection in Tari District, Southern Highlands Province, Papua New Guinea.
    Sanders RC, Lewis D, Dyke T, Alpers MP.
    P N G Med J; 1992 Sep; 35(3):197-201. PubMed ID: 1296422
    [Abstract] [Full Text] [Related]

  • 3. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
    Said ZN, El-Sayed MH, El-Bishbishi IA, El-Fouhil DF, Abdel-Rheem SE, El-Abedin MZ, Salama II.
    Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
    [Abstract] [Full Text] [Related]

  • 4. HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course.
    Sagnelli E, Coppola N, Messina V, Di Caprio D, Marrocco C, Marotta A, Onofrio M, Scolastico C, Filippini P.
    Hepatology; 2002 Nov; 36(5):1285-91. PubMed ID: 12395342
    [Abstract] [Full Text] [Related]

  • 5. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR, Mathur A, Mathur D, Udawat HP, Nepalia S, Nijhawan S, Mathur A.
    Trop Gastroenterol; 2007 Nov; 28(1):19-23. PubMed ID: 17896605
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B, Takahashi M, Nishizawa T, Endo K, Inoue J, Okamoto H.
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [Abstract] [Full Text] [Related]

  • 9. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
    Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M.
    Cancer; 1997 Dec 01; 80(11):2060-7. PubMed ID: 9392327
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep 01; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 13. HBV and HCV infection in Japanese dental care workers.
    Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M.
    Int J Mol Med; 2008 Jun 01; 21(6):791-9. PubMed ID: 18506374
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F, Gurbuz OA, Guliter S, Mert A, Songur Y, Karakan T, Keles H.
    Ren Fail; 2006 Jun 01; 28(8):729-35. PubMed ID: 17162434
    [Abstract] [Full Text] [Related]

  • 16. [Viral co-infections in hepatitis C: HBV, HBV-C/HGV and TTV studies].
    Pár A, Takács M, Brojnás J, Berencsi G, Paál M, Horányi M, Miseta A, Hegedüs G, Mózsik G, Hunyady B.
    Orv Hetil; 2004 May 09; 145(19):987-92. PubMed ID: 15181733
    [Abstract] [Full Text] [Related]

  • 17. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A, Mojiri A, Tabei SZ, Farhadi-Andarabi A, Pouransari R, Yaghobi R, Rahsaz M, Banihashemi M, Malek-Hosseini SA, Javid A, Bahador A, Reisjalali A, Behzadi S, Salehipour M, Salahl A, Davari R, Janghorban P, Torb A, Salah AR.
    Transplant Proc; 2005 Sep 09; 37(7):3045-7. PubMed ID: 16213299
    [Abstract] [Full Text] [Related]

  • 18. Incidences of HBeAg and anti-HBe in, and clinical course of hepatitis B virus carriers.
    Tsuchie H, Kurimura O, Tamura I, Shimase K, Kaneto E, Kurimura T, Tsuda F, Mayumi M.
    Biken J; 1984 Dec 09; 27(4):169-76. PubMed ID: 6100353
    [Abstract] [Full Text] [Related]

  • 19. Core promoter mutations 3 years after anti-hepatitis B e seroconversion in patients with chronic hepatitis B or hepatitis B and C infection and cancer remission.
    Zampino R, Marrone A, Karayiannis P, Cirillo G, del Giudice EM, Rania G, Utili R, Ruggiero G.
    Am J Gastroenterol; 2002 Sep 09; 97(9):2426-31. PubMed ID: 12358268
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
    Souza KP, Luz JA, Teles SA, Carneiro MA, Oliveira LA, Gomes AS, Dias MA, Gomes SA, Yoshida CF, Martins RM.
    Mem Inst Oswaldo Cruz; 2003 Jul 09; 98(5):599-603. PubMed ID: 13677340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.